Research graph
References from Survival estimation in patients with stomach and esophageal carcinoma using miRNA expression profiles. Local targets link to admitted publications; unresolved targets remain external evidence.
10.3322/caac.21660
10.3322/caac.21660 · External reference
Stomach cancer survival in the United States by race and stage (2001–2009): Findings from the CONCORD-2 study
10.1002/cncr.30881 · 2017 · External reference
Epidemiology of esophageal cancer: update in global trends, etiology and risk factors
10.1007/s12328-020-01237-x · 2020 · External reference
Gastric cancer: a comprehensive review of current and future treatment strategies
10.1007/s10555-020-09925-3 · 2020 · External reference
Esophageal cancer
2017 · External reference
10.1016/s0140-6736(10)61121-x
10.1016/s0140-6736(10)61121-x · External reference
Potential diagnostic, prognostic and therapeutic targets of MicroRNAs in human gastric cancer
2016 · External reference
miRNA-mRNA crosstalk in esophageal cancer: From diagnosis to therapy
10.1016/j.critrevonc.2015.07.002 · 2015 · External reference
MicroRNAs in tumorigenesis, metastasis, diagnosis and prognosis of gastric cancer
10.1038/cgt.2015.19 · 2015 · External reference
miRNAs involved in esophageal carcinogenesis and miRNA-related therapeutic perspectives in esophageal carcinoma
10.3390/ijms22073640 · 2021 · External reference
10.1007/s13277-013-0954-1
10.1007/s13277-013-0954-1 · External reference
MiR-616-3p promotes angiogenesis and EMT in gastric cancer via the PTEN/AKT/mTOR pathway
10.1016/j.bbrc.2018.05.109 · 2018 · External reference
Characterization and effects of miR-21 expression in esophageal cancer
10.4238/2015.august.3.4 · 2015 · External reference
Association of miR-21 with esophageal cancer prognosis: a meta-analysis
10.4238/2015.june.12.12 · 2015 · External reference
10.3892/ol.2017.6098
10.3892/ol.2017.6098 · External reference
MicroRNA-375 inhibits esophageal squamous cell carcinoma proliferation through direct targeting of SP1
2019 · External reference
MicroRNA expression profiles in gastric carcinogenesis
10.1038/s41598-018-32782-8 · 2018 · External reference
Development and validation of a serum microRNA biomarker panel for detecting gastric cancer in a high-risk population
10.1136/gutjnl-2020-322065 · 2021 · External reference
MicroRNA in the pathogenesis and prognosis of esophageal cancer
2013 · External reference
miRNAs involved in esophageal carcinogenesis and miRNA-related therapeutic perspectives in esophageal carcinoma
10.3390/ijms22073640 · 2021 · External reference
Potential miRNA biomarkers for the diagnosis and prognosis of esophageal cancer detected by a novel absolute quantitative RT-qPCR method
10.1038/s41598-020-77119-6 · 2020 · External reference
MicroRNA-575 regulates development of gastric cancer by targeting PTEN
10.1016/j.biopha.2019.108716 · 2019 · External reference
MiR-205 functions as a tumor suppressor in adenocarcinoma and an oncogene in squamous cell carcinoma of esophagus
10.1007/s13277-015-4656-8 · 2016 · External reference
Downregulation of microRNA-376a in gastric cancer and association with poor prognosis
10.1159/000495820 · 2018 · External reference
Evaluation of miR-21 and miR-375 as prognostic biomarkers in esophageal cancer
10.3109/0284186x.2015.1064161 · 2015 · External reference
Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients
10.3748/wjg.v24.i11.1206 · 2018 · External reference
Reduced miR-203 predicts metastasis and poor survival in esophageal carcinoma
10.18632/aging.102543 · 2019 · External reference
Construction of a nine-MicroRNA-based signature to predict the overall survival of esophageal cancer patients
2021 · External reference
10.1136/gut.2008.175497
10.1136/gut.2008.175497 · External reference
10.18632/oncotarget.12832
10.18632/oncotarget.12832 · External reference
Immune-Related Nine-MicroRNA Signature for Predicting the Prognosis of Gastric Cancer
10.3389/fgene.2021.690598 · 2021 · External reference
Characterization of a five-microRNA signature as a prognostic biomarker for esophageal squamous cell carcinoma
10.1038/s41598-019-56367-1 · 2019 · External reference
Inheritable genetic algorithm for biobjective 0/1 combinatorial optimization problems and its applications
10.1109/tsmcb.2003.817090 · 2004 · External reference
10.1038/s41598-017-07739-y
10.1038/s41598-017-07739-y · External reference
Identification and characterization of the lncRNA signature associated with overall survival in patients with neuroblastoma
2019 · External reference
Identification of the miRNA signature associated with survival in patients with ovarian cancer
10.18632/aging.202940 · 2021 · External reference
Applications of support vector machine (SVM) LEARNING IN CANCER GENOMIcs
2018 · External reference
Training v-support vector regression: theory and algorithms
10.1162/089976602760128081 · 2002 · External reference
Intelligent evolutionary algorithms for large parameter optimization problems
10.1109/tevc.2004.835176 · 2004 · External reference
Identifying a miRNA signature for predicting the stage of breast cancer
2018 · External reference
Novel miRNA signature for predicting the stage of hepatocellular carcinoma
2020 · External reference
Computational identification of ubiquitylation sites from protein sequences
2008 · External reference
10.1080/00401706.1970.10488634
10.1080/00401706.1970.10488634 · External reference
Regression Shrinkage and Selection Via the Lasso
10.1111/j.2517-6161.1996.tb02080.x · 1996 · External reference
Regularization and variable selection via the elastic net
10.1111/j.1467-9868.2005.00503.x · 2005 · External reference
miRTarBase 2020: updates to the experimentally validated microRNA-target interaction database
2020 · External reference
10.1186/1471-2105-14-128
10.1186/1471-2105-14-128 · External reference
10.1093/nar/gkw377
10.1093/nar/gkw377 · External reference
10.1093/nar/gkv1024
10.1093/nar/gkv1024 · External reference
10.1016/j.cels.2015.12.004
10.1016/j.cels.2015.12.004 · External reference
10.1093/nar/gkaa1113
10.1093/nar/gkaa1113 · External reference
CancerMIRNome: an interactive analysis and visualization database for miRNome profiles of human cancer
10.1093/nar/gkab784 · 2022 · External reference
DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA-gene interactions
10.1093/nar/gkx1141 · 2018 · External reference
10.1093/nar/gkn851
10.1093/nar/gkn851 · External reference
10.1093/nar/gkaa467
10.1093/nar/gkaa467 · External reference
HMDD v3.0: a database for experimentally supported human microRNA-disease associations
10.1093/nar/gky1010 · 2019 · External reference
miR-760 exerts an antioncogenic effect in esophageal squamous cell carcinoma by negatively driving fat metabolism via targeting c-Myc
10.1002/jcb.29540 · 2020 · External reference
Identifying the differentially expressed microRNAs in esophagus squamous cell carcinoma of Kazakh patients in Xinjiang
2019 · External reference
miR-1301-3p promotes cell proliferation and facilitates cell cycle progression via targeting SIRT1 in gastric cancer
2021 · External reference
A novel three-miRNA signature identified using bioinformatics predicts survival in esophageal carcinoma
10.1155/2020/5973082 · 2020 · External reference
LINC01410-miR-532-NCF2-NF-kB feedback loop promotes gastric cancer angiogenesis and metastasis
10.1038/s41388-018-0162-y · 2018 · External reference
Low expression of miR-29a is associated with aggressive biology and worse survival in gastric cancer
10.1038/s41598-021-93681-z · 2021 · External reference
10.7150/thno.10305
10.7150/thno.10305 · External reference
MicroRNA profiling in oesophageal adenocarcinoma cell lines and patient serum samples reveals a role for miR-451a in radiation resistance
10.3390/ijms21238898 · 2020 · External reference
miR-23b-3p and miR-130a-5p affect cell growth, migration and invasion by targeting CB1R via the Wnt/β-catenin signaling pathway in gastric carcinoma
10.2147/ott.s181706 · 2018 · External reference
10.1158/0008-5472.can-17-0530
10.1158/0008-5472.can-17-0530 · External reference
By downregulating TIAM1 expression, microRNA-329 suppresses gastric cancer invasion and growth
10.18632/oncotarget.2755 · 2015 · External reference
miR-496 inhibits proliferation via LYN and AKT pathway in gastric cancer
10.1515/med-2021-0313 · 2021 · External reference
Growth hormone-releasing hormone receptor antagonists inhibit human gastric cancer through downregulation of PAK1-STAT3/NF-κB signaling
10.1073/pnas.1618582114 · 2016 · External reference
10.1038/nrm3434
10.1038/nrm3434 · External reference
10.1038/s41580-018-0007-0
10.1038/s41580-018-0007-0 · External reference
10.1016/j.canlet.2016.03.033
10.1016/j.canlet.2016.03.033 · External reference
10.1177/107327481302000106
10.1177/107327481302000106 · External reference
10.1016/j.pharmthera.2014.11.001
10.1016/j.pharmthera.2014.11.001 · External reference
10.1038/s41392-020-00436-9
10.1038/s41392-020-00436-9 · External reference
Bcl-2-associated transcription factor 1 Ser290 phosphorylation mediates DNA damage response and regulates radiosensitivity in gastric cancer
10.1186/s12967-021-03004-z · 2021 · External reference
Cancer-associated fibroblast–promoted LncRNA <em>DNM3OS</em> confers radioresistance by regulating DNA damage response in esophageal squamous cell carcinoma
10.1158/1078-0432.ccr-18-0773 · 2019 · External reference
HER2-targeted therapies in gastric cancer
10.1016/j.bbcan.2021.188549 · 2021 · External reference
Epidermal growth factor receptor (EGFR)-targeted therapies in esophagogastric cancer
2013 · External reference
10.7150/ijbs.43630
10.7150/ijbs.43630 · External reference
Angiogenesis and anti-angiogenic therapy in gastric cancer
10.3390/ijms19010043 · 2017 · External reference
10.1038/onc.2016.34
10.1038/onc.2016.34 · External reference
